Overview

Idiopathic Anemia of Aging (IAA)

Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Aging (NIA)
Treatments:
Epoetin Alfa